Back
Day Range
$286.56
$295.37
52-Week Range
$273.71
$458.75
Volume
1,348,774
50D / 200D Avg
$331.17
/
$331.99
Prev Close
$291.48
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 11.3 | 0.4 |
| P/B | 1.5 | 2.9 |
| ROE % | 13.3 | 3.8 |
| Net Margin % | 2.8 | 3.9 |
| Rev Growth 5Y % | 9.5 | 10.0 |
| D/E | 0.8 | 0.2 |
Key Takeaways
Revenue grew 9.47% annually over 5 years — modest growth
ROE of 13.29% — decent returns on equity
Generating 3.17B in free cash flow
P/E of 11.27 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.15%
Capital efficient — spends only 0.56% of revenue on capex
Growth
Revenue Growth (5Y)
9.47%
Revenue (1Y)12.62%
Earnings (1Y)-5.32%
FCF Growth (3Y)-31.50%
Quality
Return on Equity
13.29%
ROIC7.89%
Net Margin2.84%
Op. Margin4.07%
Safety
Debt / Equity
0.76
Current Ratio1.24
Interest Coverage5.79
Valuation
P/E Ratio
11.27
P/B Ratio1.45
EV/EBITDA10.80
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12.62% | Revenue Growth (3Y) | 7.80% |
| Earnings Growth (1Y) | -5.32% | Earnings Growth (3Y) | -2.75% |
| Revenue Growth (5Y) | 9.47% | Earnings Growth (5Y) | -1.86% |
| Profitability | |||
| Revenue (TTM) | 199.13B | Net Income (TTM) | 5.66B |
| ROE | 13.29% | ROA | 4.66% |
| Gross Margin | 25.56% | Operating Margin | 4.07% |
| Net Margin | 2.84% | Free Cash Flow (TTM) | 3.17B |
| ROIC | 7.89% | FCF Growth (3Y) | -31.50% |
| Safety | |||
| Debt / Equity | 0.76 | Current Ratio | 1.24 |
| Interest Coverage | 5.79 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 11.27 | P/B Ratio | 1.45 |
| P/S Ratio | 0.32 | PEG Ratio | -5.63 |
| EV/EBITDA | 10.80 | Dividend Yield | 0.02% |
| Market Cap | 63.84B | Enterprise Value | 87.58B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 199.13B | 176.81B | 171.34B | 156.60B | 138.64B |
| Net Income | 5.66B | 5.98B | 5.99B | 5.89B | 6.10B |
| EPS (Diluted) | 25.12 | 25.68 | 25.22 | 24.28 | 24.73 |
| Gross Profit | 50.90B | 49.24B | 47.01B | 39.95B | 35.99B |
| Operating Income | 8.11B | 8.89B | 8.75B | 8.45B | 8.95B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 121.49B | 116.89B | 108.93B | 102.76B | 97.46B |
| Total Liabilities | 77.47B | 75.46B | 69.52B | 66.43B | 61.33B |
| Shareholders' Equity | 43.88B | 41.32B | 39.31B | 36.24B | 36.06B |
| Total Debt | 33.24B | 32.70B | 26.65B | 25.80B | 24.89B |
| Cash & Equivalents | 9.49B | 8.29B | 6.53B | 7.39B | 4.88B |
| Current Assets | 24.73B | 21.34B | 18.99B | 19.13B | 14.57B |
| Current Liabilities | 19.96B | 19.42B | 19.55B | 18.65B | 15.53B |